RICE HALL JAMES & ASSOCIATES, LLC – Neurocrine Biosciences, Inc. Transaction History
RICE HALL JAMES & ASSOCIATES, LLC portfolio value:
$16.24M
portfolio value
RICE HALL JAMES & ASSOCIATES, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -24.50% | -49.62K shares | -3.50M | $106.21 | 152.91K |
| Q2 2022 | share | Decrease | -2.04% | -4.20K shares | 361K | $97.48 | 202.54K |
| Q1 2022 | share | Increase | +195.48% | 136.78K shares | 13.42M | $93.75 | 206.75K |
| Q4 2021 | share | Decrease | -10.32% | -8.05K shares | -1.52M | $84.63 | 69.97K |
| Q3 2021 | share | Decrease | -6.28% | -5.23K shares | -619K | $95.91 | 78.02K |
| Q2 2021 | share | Decrease | -0.02% | -14 shares | 4K | $97.32 | 83.25K |
| Q1 2021 | share | Decrease | -4.42% | -3.84K shares | -252K | $97.25 | 83.27K |
| Q4 2020 | share | Increase | +17.44% | 12.93K shares | 1.21M | $95.85 | 87.11K |
| Q3 2020 | share | Increase | +14.05% | 9.14K shares | -802K | $96.16 | 74.18K |
| Q2 2020 | share | Decrease | -1.50% | -993 shares | 2.22M | $122 | 65.04K |
| Q1 2020 | share | Decrease | -1.23% | -824 shares | -1.47M | $86.55 | 66.03K |
| Q4 2019 | share | Increase | +8.72% | 5.36K shares | 1.64M | $107.49 | 66.85K |
| Q3 2019 | share | Decrease | -1.05% | -654 shares | 294K | $90.11 | 61.49K |
| Q2 2019 | share | Decrease | -15.70% | -11.57K shares | -1.24M | $84.43 | 62.14K |
| Q1 2019 | share | Increase | +68.55% | 29.98K shares | 3.37M | $88.1 | 73.72K |
| Q4 2018 | share | Increase | 0.00% | 43.74K shares | 3.12M | $71.41 | 43.74K |